Ulocuplumab, CAS [[1375830-34-4]]
Artikelnummer:
MCE-HY-P99272
| Artikelname: |
Ulocuplumab, CAS [[1375830-34-4]] |
| Artikelnummer: |
MCE-HY-P99272 |
| Hersteller Artikelnummer: |
HY-P99272 |
| Alternativnummer: |
MCE-HY-P99272-1MG,MCE-HY-P99272-10MG,MCE-HY-P99272-5MG,MCE-HY-P99272-25MG,MCE-HY-P99272-50MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Antikörper |
| Alternative Synonym: |
BMS 936564, MDX 1338, Anti-Human CXCR4 Recombinant Antibody |
| Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models[1][2]. |
| Molekulargewicht: |
(144.84 kDa) |
| Reinheit: |
99.90 |
| CAS Nummer: |
[1375830-34-4] |
| Target-Kategorie: |
CXCR |
| Anwendungsbeschreibung: |
MCE Product type: Inhibitory Antibodies |
